Followers

Showing posts with label ADHD research. Show all posts
Showing posts with label ADHD research. Show all posts

ADHD Only Research Study In Sydney: You Can Participate For Free

>> Tuesday, May 4, 2010

For those in Australia, there is a participation opportunity for those who are parents of ADHD (Attention Deficit Hyperactivity Disorder). The Sydney University Faculty of Health Sciences are looking for participants for a play- based intervention program that assists children with ADHD to help develop their social interactions with others. This will also help them in learning how to build friendships.

"In a previous study involving 350 children, we discovered that the play of children with ADHD differed from that of their peers," says Professor Anita Bundy.

The program takes seven week including assessment of social language, play skills, and play-based intervention. They are seeking children between the ages of 5 and 11 years old, having a confirmed diagnosis of ADHD. Children can participate in the program if they have conditions commonly occurring with ADHD (learning disorders and oppositional defiant disorder) provided ADHD is the primary diagnosis.

Children will not be able to participate if they have other major developmental or psychiatric disorders (autism, intellectual disability, and cerebral palsy). Participants will be required to have functional English skills to participate. The program is free and you can learn more about the ADHD only play-based intervention study in Sydney, Australia from The Medical News.

Read more...

NKPL: A Treatment For ADHD

>> Wednesday, November 18, 2009

NKPL is a highly concentrated phospholipid extract that may be an effective treatment for children with ADHD and is possibly a safe alternative to Ritalin. Neptune Technologies and Bioressources Inc. has reports on the first preclinical research update on NeuroBioPharm Inc. medical food development program. You can read more about this story in the news article on Neptune and Bioressources Inc.

"NeuroBioPharm Inc. announces the results of preclinical research performed by NeuroCode AG, (Wetzlar, Germany).The objectives of the trial were a) to determine the nature and extent of effect of the new NBP medical food candidate NKPL on the electrical activity of the brain, and b) to characterize the EEG effects in relation to standard central nervous system (CNS) drugs."

They are hoping that this will be an effective treatment to ADHD, and is aimed to improve the cognitive and emotional health of children and adults.

I hope that you all have a great day, and as always your thoughts are appreciated greatly.


Read more...